GlassScriptPhysician profile
Lori A Hanrahan
NPI 1366798209
$2,979.19
in general payments reported to CMS, 2019-2025
37 companies · $897 in 2025
The $897 reported for 2025 was more than what 85% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $223 · 2022: $159 · 2023: $1,064 · 2024: $636 · 2025: $897.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,214 · Education: $351 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $31.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,214.31 |
| Education | $351.40 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $31.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $396.78 | 2023-2024 | Xtandi, Myrbetriq |
| Janssen Biotech, INC. | $308.36 | 2023-2025 | Erleada, Akeega |
| Bayer Healthcare Pharmaceuticals INC. | $271.82 | 2023-2025 | |
| Sumitomo Pharma America, INC. | $271.09 | 2023-2025 | Gemtesa |
| Pfizer INC. | $213.76 | 2023-2025 | |
| Dendreon Pharmaceuticals LLC | $153.27 | 2024-2025 | Provenge |
| Urogen Pharma, INC. | $142.04 | 2023-2025 | Jelmyto |
| Accord Healthcare, INC. | $100.41 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $84.29 | 2021-2025 | |
| Sun Pharmaceutical Industries INC. | $78.79 | 2023-2024 | Yonsa |
| Progenics Pharmaceuticals, INC. | $70.97 | 2023-2025 | Pylarify |
| Boehringer Ingelheim Pharmaceuticals, INC. | $70.52 | 2021 | |
| Immunitybio, INC. | $68.10 | 2025 | |
| Procept Biorobotics Corporation | $65.71 | 2023 | Aquabeam Robotic System |
| Medtronic, INC. | $62.06 | 2024-2025 | Interstim, Altaviva |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lori Hanrahan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.